This adaptive PTEN loss in brain metastatic tumor cells led to an increased secretion of the chemokine CCL2, which recruits IBA1-expressing myeloid cells that reciprocally enhanced the outgrowth of brain metastatic tumor cells via enhanced proliferation and reduced apoptosis (Zhang et al., 2015). This evidence concerns the gene AIF1 and neoplasm.